Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma

FOLFIRINOX is one of the most effective reference regimens in the 1st line treatment of locally advanced (LA) and metastatic pancreatic cancer (mPC), despite its high toxicity. We evaluated our real-life experience with “patient-tailored intent to treat FOLFIRINOX” in patients with LA or mPC compare...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Ulusakarya, Ayhan, Teyar, Nahla, Karaboué, Abdoulaye, Haydar, Mazen, Krimi, Sarra, Biondani, Pamela, Gumus, Yusuf, Chebib, Amale, Almohamad, Wathek, Morère, Jean-François
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494255/
https://ncbi.nlm.nih.gov/pubmed/31008993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000015341
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados